Rodrigo Orellana

ORCID: 0009-0005-4581-5769
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Healthcare cost, quality, practices
  • Gestational Diabetes Research and Management
  • Oral and gingival health research
  • Antibiotic Use and Resistance
  • Diabetes Treatment and Management
  • Ovarian function and disorders
  • Pregnancy and preeclampsia studies
  • Diabetes Management and Research

Hospital Clínico de la Universidad de Chile
2017

Abstract Background Antimicrobial resistance (AMR) is a global concern. Collecting data and implementing interventions to optimize antimicrobial (AM) use has significant potential lower AMR.There no information in Latin American Region on how prescribers are using from positive blood culture results de-escalate AM. We present sub-analysis of the 2022-2023 Latin-PPS performed Chile including characterization bacteriemia de-escalation practices. distribution treat bacteremia Methods 13 public...

10.1093/ofid/ofae631.1850 article EN cc-by Open Forum Infectious Diseases 2025-01-29

Abstract Aim We aimed to assess the use of metformin ( MTF ) in prevention gestational diabetes mellitus GDM patients with pregestational insulin resistance PIR ). Methods A double blind, multicenter, randomized trial was carried out a history and treatment. Groups were allocated either 1700 mg/day or placebo. Patients recruited between 12 +0 15 +6 weeks, treatment extended until week 36. multiple logistic regression analysis applied determine relation development . Results One hundred forty...

10.1111/jog.13477 article EN Journal of Obstetrics and Gynaecology Research 2017-11-02

Background Type 2 diabetes mellitus is a highly prevalent disease and associated with increased morbidity mortality. Due to the low percentage of adequate glycemic control, new strategies for treatment type have been sought, including sodium-glucose cotransporter inhibitorss. Objective To describe evolution patients insulin requirements treated empagliflozin at Peñaflor Hospital. The primary objective was evaluate efficacy medication regarding glycosylated hemoglobin A1c (HbA1c). secondary...

10.5867/medwave.2024.03.2758 article EN cc-by-nc Medwave 2024-04-17
Coming Soon ...